On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the most-favored-nation, or MFN price.

The agreement is with EMD Serono, a unit of Merck KGaA (OTC:MKGAF) (OTC:MKKGY), for its fertility treatments, resulting in substantial cost savings on fertility treatments, including:

GONAL-F, a commonly used fertility medication, will be made available to women purchasing directly from TrumpRx.gov at a discount equal to 796% of the deal price.

Low- and middle-income women (those with incomes below 550% of the Federal poverty level) will receive an additional discount totaling 2,320% of the deal price when purchasing from TrumpRx.gov.

The Centers for Medicare and Medicaid Services estimates women ...